Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.
- S. Klahr, J. Breyer, M. E. Yamamoto
- MedicineJournal of the American Society of Nephrology
- 1 June 1995
Lower protein intake, but not prescription of the keto acid-amino acid supplement, was marginally associated with a slower progression of renal disease, and the rate of decline was faster in participants with ADPKD than in persons with other diagnoses.
Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.
- A. Moustapha, A. Naso, V. Dennis
- Medicine, BiologyCirculation
- 20 January 1998
These prospective observations confirm that hyperhomocysteinemia is an independent risk factor for cardiovascular morbidity and mortality in end-stage renal disease, with an increased RR of 1% per micromol/L increase in total homocysteine concentration.
Sulfate transport in rabbit proximal convoluted tubules: presence of anion exchange.
The data indicate that sulfate transport in the proximal convoluted tubule is bidirectional, independent of phosphate transport, and occurs via two forms of facilitated transport, one of which is an anion exchange mechanism.
The Effect of Amphotericin B on the Water and Nonelectrolyte Permeability of Thin Lipid Membranes
- T. Andreoli, V. Dennis, A. Weigl
- BiologyThe Journal of General Physiology
- 1 February 1969
These data were compatible with the hypothesis that the interactions of amphotericin B with membrane-bound cholesterol result in the formation of pores whose equivalent radii are in the range 7 to 10 A, with the effective hydrodynamic radii of the solutes tested.
Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.
- K. Robinson, A. Gupta, D. Jacobsen
- Medicine, BiologyCirculation
- 1 December 1996
A high total plasma homocysteine concentration is an independent risk factor for atherosclerotic complications of end-stage renal disease and patients with such patients may benefit from higher doses of B vitamins than those currently recommended.
Analgesic use and chronic renal disease.
- D. Sandler, J. Smith, W. Burgess
- MedicineNew England Journal of Medicine
- 11 May 1989
The long-term, regular use of phenacetin may increase the risk of chronic renal disease and acetaminophen, the major metabolite of Phenacetin, is associated independently with an increased risk of Chronic renal disease.
Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients.
- E. Poggio, Patrick C. Nef, P. Hall
- MedicineAmerican Journal of Kidney Diseases
- 1 August 2005
Estimation equations are performed poorly compared with iGFR and are not reliable measures of actual level of function in sick hospitalized patients, especially those with a high BUN/SCr ratio.
Feasibility and benefits of exercise training in patients on maintenance dialysis.
- R. Shalom, J. Blumenthal, R. S. Williams, R. Mcmurray, V. Dennis
- Medicine, PsychologyKidney International
- 1 June 1984
It is concluded that exercise conditioning can improve physical work capacity in patients with chronic renal failure who are receiving maintenance dialysis treatment and that those who did not attend regularly had higher scores for hostility, anxiety, and depression as compared to those patients who completed the program.
Hemodialysis-associated subclavian vein stenosis.
- S. Schwab, L. Quarles, J. Middleton, R. Cohan, M. Saeed, V. Dennis
- Medicine, BiologyKidney International
- 1 June 1988
It is concluded that SVS is a common dialysis problem that is amenable to treatment with PTA and lowering venous dialysis pressure and restoring patency to the fistula in 100%.
Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis.
- A. Moustapha, A. Gupta, V. Dennis
- Medicine, BiologyKidney International
- 1 April 1999
Hyperhomocysteinemia is more prevalent and intense in HD patients compared with those on peritoneal dialysis, and the homocysteine response may become refractory to excess folate supplementation in PD patients.
...
...